ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

New Non-Antibiotic Treatment Shows Promise Against S. Aureus

by Mary Beth Nierengarten • January 8, 2016

  • Tweet
  • Email
Print-Friendly Version

A novel non-antibiotic treatment approach for chronic and nosocomial infections caused by Staphylococcus aureus biofilms shows promise in offering a way to combat these increasingly difficult-to-treat infections.

You Might Also Like

  • Novel Antibiotic To Solve the Antibiotic Crisis?
  • Pregabalin Shows Promise as Treatment Option for Laryngeal Sensory Neuropathy
  • Computational Modeling Shows Promise for Otolaryngology Use
  • Computational Modeling Shows Promise for Otolaryngology Use

A recent study by investigators from the University of Adelaide in Australia showed the efficacy of treating S. aureus biofilms in vitro with two compounds that target the essential iron metabolism for bacterial growth, pathogenesis, and survival. The data was presented at the American Rhinologic Society’s annual meeting in Dallas in September, 2015. [PDF].

“The first compound deferiprone (Def) diverts essential nutrients from bacteria, leaving them vulnerable, while the second compound gallium-protoporphyrin (GaPP) kills them,” said lead investigator of the study, Katharina Richter, a PhD student in the ear, nose, and throat surgery department at The Queen Elizabeth Hospital and Basil Hetzel Institute for Translational Health Research at the University of Adelaide’s, Australia. “The bacteria starve and die,” she said.

The efficacy of this treatment approach was significantly enhanced by delivering the two compounds consecutively versus individually. The study found a 95% efficacy in removing biofilms with consecutive treatment that consisted of two hours of Def (20 mM) followed by two hours of GaPP (200 µg/mL). When delivered individually, biofilm removal was achieved in 35% after DEF monotherapy and 74% after GaPP monotherapy. When delivered together, 55% achieved biofilm removal.

In addition to efficacy, the study found no toxicity to the two cell lines.

According to Richter, additional in vitro studies, including an animal study, not yet published, confirm the efficacy of this treatment approach against MRSA and other bacteria.

A clinical trial is expected to begin later this year that will test a novel drug-delivery-system for clinical use that incorporates this treatment approach.

“This smart medicine approach is envisaged to aid wound healing after sinus surgery and treat biofilm-associated chronic rhinosinusitis topically at the site of infection,” she said, adding that the benefits of this approach are fewer side effects, systemic effects, and interactions with other drugs and food.

Filed Under: Online Exclusives Tagged With: infection

You Might Also Like:

  • Novel Antibiotic To Solve the Antibiotic Crisis?
  • Pregabalin Shows Promise as Treatment Option for Laryngeal Sensory Neuropathy
  • Computational Modeling Shows Promise for Otolaryngology Use
  • Computational Modeling Shows Promise for Otolaryngology Use

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Non-Acidic Reflux Explains Lack of Response to H2 Blockers and PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.